Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain
- PMID: 24698864
- DOI: 10.1038/ajg.2013.480
Rifaximin for episodic, overt hepatic encephalopathy: the data are catching up to clinical practice, but questions remain
Comment in
-
Response to Congly and Leise.Am J Gastroenterol. 2014 Apr;109(4):598-9. doi: 10.1038/ajg.2013.482. Am J Gastroenterol. 2014. PMID: 24698865 No abstract available.
Comment on
-
A randomized, double-blind, controlled trial comparing rifaximin plus lactulose with lactulose alone in treatment of overt hepatic encephalopathy.Am J Gastroenterol. 2013 Sep;108(9):1458-63. doi: 10.1038/ajg.2013.219. Epub 2013 Jul 23. Am J Gastroenterol. 2013. PMID: 23877348 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources